Results 201 to 210 of about 10,843 (242)

Measures of cellular oxidative damage following vitamin E supplementation in young patients with transfusion-dependent thalassemia: a double-blind randomized controlled trial. [PDF]

BMC Pediatr
Hemprachitchai N, Praneetponkang R, Wongwerawattanakoon P, Wongborisuth C, Innachai P, Kadegasem P, Khlangtan T, Sriwantana T, Phoonlapdacha P, Dumrongwongsiri O, Chuansumrit A, Pattanapanyasat K, Sirachainan N, Sibmooh N, Chaichompoo P, Songdej D.   +15 more
europepmc   +1 more source

Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic Risk. [PDF]

Clin Appl Thromb Hemost
Al-Sanabra OM, Abbas MA, Hazà WJ, Hazàa AA, Al Tibi AK.   +4 more
europepmc   +1 more source

Deferiprone-resveratrol hybrid attenuates iron accumulation, oxidative stress, and antioxidant defenses in iron-loaded human Huh7 hepatic cells. [PDF]

Front Mol Biosci
Li J, Koonyosying P, Korsieporn W, Paradee N, Hutachok N, Xu H, Ma Y, Chuljerm H, Srichairatanakool S.   +8 more
europepmc   +1 more source

Ferroptosis and endoplasmic reticulum stress in rheumatoid arthritis. [PDF]

Front Immunol
Ao Q, Hu H, Huang Y.
europepmc   +1 more source

Mitochondrial Unfolded Protein Response (mtUPR) Activation Improves Pathological Alterations in Cellular Models of Ethylmalonic Encephalopathy. [PDF]

Antioxidants (Basel)
Romero-Domínguez JM, Cilleros-Holgado P, Gómez-Fernández D, Piñero-Pérez R, Reche-López D, Romero-González A, Álvarez-Córdoba M, López-Cabrera A, De Oliveira MC, Rodríguez-Sacristán A, González-Granero S, García-Verdugo JM, Aroca A, Sánchez-Alcázar JA.   +13 more
europepmc   +1 more source

Beta thalassemia syndromes: New insights.

World J Clin Cases
Dordevic A, Mrakovcic-Sutic I, Pavlovic S, Ugrin M, Roganovic J.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

JAMA Neurology
Importance Interventions that substantially slow neurodegeneration are needed to address the growing burden of Alzheimer disease (AD) to societies worldwide.
S. Ayton, David Barton, B. Brew, A. Brodtmann, R. Clarnette, Patricia Desmond, David Devos, Kathryn A. Ellis, Amir Fazlollahi, C. Fradette, Anita M Y Goh, P. Kalinowski, C. Kyndt, Rosalyn Lai, Y. Y. Lim, P. Maruff, Terence J O'Brien, Christopher Rowe, Olivier Salvado, Peter W. Schofield, M. Spino, F. Tricta, Aaron Wagen, Robert Williams, Michael Woodward, Ashley I Bush   +25 more
semanticscholar   +5 more sources

An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes

Expert Review of Hematology, 2023
Introduction Regular blood transfusions in patients with thalassemia syndromes can cause iron overload resulting in complications including cirrhosis, heart problems, or endocrine abnormalities.
Richa Shah, Aashaka C Shah, S. Badawy
semanticscholar   +1 more source

Longitudinal prospective comparison of pancreatic iron by magnetic resonance in thalassemia patients transfusion-dependent since early childhood treated with combination deferiprone-desferrioxamine vs deferiprone or deferasirox monotherapy

Blood transfusion = Trasfusione del sangue, 2023
Background In transfusion-dependent thalassemia patients who started regular transfusions in early childhood, we prospectively and longitudinally evaluated the efficacy on pancreatic iron of a combined deferiprone (DFP) + desferrioxamine (DFO) regimen ...
P. Ricchi, A. Meloni, L. Pistoia, M. Gamberini, L. Cuccia, Massimo Allò, M. Putti, A. Spasiano, R. Rosso, V. Cecinati, R. Righi, S. Renne, G. Peritore, A. Vallone, V. Positano, E. Quaia, Filippo Cademartiri, A. Pepe   +17 more
semanticscholar   +1 more source